SNDL (SNDL) Competitors

SNDL (NASDAQ:SNDL) and ANI Pharmaceuticals (NASDAQ:ANIP) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

Do analysts rate SNDL or ANIP?

SNDL currently has a consensus target price of $3.63, suggesting a potential upside of 173.58%. ANI Pharmaceuticals has a consensus target price of $80.13, suggesting a potential upside of 27.95%. Given SNDL's higher possible upside, analysts clearly believe SNDL is more favorable than ANI Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ANI Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more volatility & risk, SNDL or ANIP?

SNDL has a beta of 3.45, indicating that its share price is 245% more volatile than the S&P 500. Comparatively, ANI Pharmaceuticals has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in SNDL or ANIP?

76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 12.7% of ANI Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has higher valuation & earnings, SNDL or ANIP?

ANI Pharmaceuticals has lower revenue, but higher earnings than SNDL. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$927.61M	0.38	-$127.91M	-$0.29	-4.57
ANI Pharmaceuticals	$674.07M	2.01	$18.78M	-$1.27	-49.31

Does the MarketBeat Community prefer SNDL or ANIP?

ANI Pharmaceuticals received 300 more outperform votes than SNDL when rated by MarketBeat users. However, 71.94% of users gave SNDL an outperform vote while only 64.19% of users gave ANI Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
SNDL	Outperform Votes 141 71.94%	Underperform Votes 55 28.06%
ANI Pharmaceuticals	Outperform Votes 441 64.19%	Underperform Votes 246 35.81%

Is SNDL or ANIP more profitable?

ANI Pharmaceuticals has a net margin of -1.28% compared to SNDL's net margin of -12.11%. ANI Pharmaceuticals' return on equity of 15.87% beat SNDL's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-12.11%	-8.27%	-6.96%
ANI Pharmaceuticals	-1.28%	15.87%	6.88%

Does the media prefer SNDL or ANIP?

In the previous week, ANI Pharmaceuticals had 4 more articles in the media than SNDL. MarketBeat recorded 6 mentions for ANI Pharmaceuticals and 2 mentions for SNDL. ANI Pharmaceuticals' average media sentiment score of 1.58 beat SNDL's score of 0.96 indicating that ANI Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SNDL	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ANI Pharmaceuticals	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

ANI Pharmaceuticals beats SNDL on 12 of the 18 factors compared between the two stocks.